Pradat P - Search Results

1

Incidence and Risk Factors of Coagulation Profile Derangement After Liver Surgery: Implications for the Use of Epidural Analgesia-A Retrospective Cohort Study.

Jacquenod P, Wallon G, Gazon M, Darnis B, Pradat P, Virlogeux V, Farges O, Aubrun F. Jacquenod P, et al. Among authors: pradat p. Anesth Analg. 2018 Apr;126(4):1142-1147. doi: 10.1213/ANE.0000000000002457. Anesth Analg. 2018. PMID: 28922227

2

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score.

Virlogeux V, Pradat P, Bailly F, Funingana G, Gonçalves F, Maynard M, Hartig-Lavie K, Amiri M, Zoulim F. Virlogeux V, et al. Among authors: pradat p. J Viral Hepat. 2014;21(9):e98-e107. doi: 10.1111/jvh.12237. Epub 2014 Feb 25. J Viral Hepat. 2014. PMID: 24612466

3

Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.

Bailly F, Virlogeux V, Dufour C, Pradat P, Hézode C, Larrey D, Alric L, Samuel D, Bourlière M, Métivier S, Zarski JP, Fontaine H, Loustaud-Ratti V, Serfaty L, Bronowicki JP, Carrat F, Zoulim F; CUPIC Study Group. Bailly F, et al. Among authors: pradat p. Clin Res Hepatol Gastroenterol. 2015 Sep;39(4):443-50. doi: 10.1016/j.clinre.2014.12.007. Epub 2015 Jan 27. Clin Res Hepatol Gastroenterol. 2015. PMID: 25636238

4

Anti-E1E2 antibodies do predict response to triple therapy in treatment-experienced Hepatitis C Virus-cirrhosis cases.

Petit MA, Berthillon P, Pradat P, Arnaud C, Bordes I, Virlogeux V, Maynard M, Bailly F, Zoulim F, Chemin I, Trépo C. Petit MA, et al. Among authors: pradat p. Clin Res Hepatol Gastroenterol. 2015 Dec;39(6):699-704. doi: 10.1016/j.clinre.2015.03.002. Epub 2015 Apr 18. Clin Res Hepatol Gastroenterol. 2015. PMID: 25900002

5

Antiviral Therapy in Patients with Hepatitis C Virus-Induced Cirrhosis.

Bailly F, Pradat P, Virlogeux V, Zoulim F. Bailly F, et al. Among authors: pradat p. Dig Dis. 2015;33(4):613-23. doi: 10.1159/000375359. Epub 2015 Jul 6. Dig Dis. 2015. PMID: 26159282

6

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy.

Pradat P, Virlogeux V, Maynard M, Leclercq M, Hatu G, Amiri M, Lebosse F, Miailhes P, Zoulim F, Gagnieu MC, Bailly F. Pradat P, et al. Hepat Mon. 2015 Sep 1;15(9):e28879. doi: 10.5812/hepatmon.28879. eCollection 2015 Sep. Hepat Mon. 2015. PMID: 26500683 Free PMC article.

7

Sofosbuvir plus daclatasvir with or without ribavirin for chronic hepatitis C infection: Impact of drug concentration on viral load decay.

Virlogeux V, Choupeaux L, Pradat P, Maynard M, Bailly F, Scholtès C, Gagnieu MC, Zoulim F. Virlogeux V, et al. Among authors: pradat p. Dig Liver Dis. 2016 Nov;48(11):1351-1356. doi: 10.1016/j.dld.2016.07.014. Epub 2016 Jul 21. Dig Liver Dis. 2016. PMID: 27498075

8

Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.

Virlogeux V, Pradat P, Hartig-Lavie K, Bailly F, Maynard M, Ouziel G, Poinsot D, Lebossé F, Ecochard M, Radenne S, Benmakhlouf S, Koffi J, Lack P, Scholtes C, Uhres AC, Ducerf C, Mabrut JY, Rode A, Levrero M, Combet C, Merle P, Zoulim F. Virlogeux V, et al. Among authors: pradat p. Liver Int. 2017 Aug;37(8):1122-1127. doi: 10.1111/liv.13456. Epub 2017 May 25. Liver Int. 2017. PMID: 28423231

9

Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.

Virlogeux V, Berthillon P, Bordes I, Larrat S, Crouy S, Scholtès C, Pradat P, Maynard M, Zoulim F, Leroy V, Chemin I, Trépo C, Petit MA. Virlogeux V, et al. Among authors: pradat p. Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):313-318. doi: 10.1016/j.clinre.2018.02.002. Epub 2018 Mar 16. Clin Res Hepatol Gastroenterol. 2018. PMID: 29551607

10

Benefit of direct-acting antiviral therapy for hepatitis C virus (HCV) in monoinfected and HIV-HCV-coinfected patients with mixed cryoglobulinaemia.

Miailhes P, Hartig-Lavie K, Virlogeux V, Pradat P, Diakite M, Uhres AC, Zoulim F, Sarda MN. Miailhes P, et al. Among authors: pradat p. Clin Microbiol Infect. 2018 Nov;24(11):1215.e1-1215.e4. doi: 10.1016/j.cmi.2018.05.019. Epub 2018 Jun 2. Clin Microbiol Infect. 2018. PMID: 29870852 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

415 results

Search Page

Filters